Capsugel® Vcaps® DPI capsules are a high-quality solution based on HPMC polymer with a gelling system. They are available with a wide range of customizable color combinations (transparent or opaque) and print options. Capsugel® Vcaps® DPI capsules are robust with LOD below 9% or up to less than 2.2% LWA (low water activity). They have a very low powder retention profile, matte surface and are available in sizes 3 and 00.
Every product development need varies based on the desired performance of the finished product. Lonza partners with its customers to closely match specific requirements and leverages a wide range of customization services for its Capsugel® Zephyr™ capsule portfolio.
Learn more about our capabilities and which Capsugel® Zephyr™ product is right for your next project.
Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication.
Within the dry powder inhalation application fields, Lonza offers a portfolio of high-quality capsule solutions based on different polymers, tailored to enable consistent and optimal release performance. Building on a history of innovation in polymer science and capsule engineering, the Capsugel® brand, now part of Lonza, offers a suite of HPMC and alternate polymer capsules for the pharmaceutical world.